TrustCore Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

TrustCore Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$28	Hold	1	–	–	﹤0.01%	1031
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1051
2022 Q2	$0	Hold	1	–	–	﹤0.01%	1030
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1024
2021 Q4	$0	Hold	1	–	–	﹤0.01%	939
2021 Q3	$0	Hold	1	–	–	﹤0.01%	1018
2021 Q2	$0	Hold	1	–	–	﹤0.01%	1058
2021 Q1	$0	Hold	1	–	–	﹤0.01%	916
2020 Q4	$0	Buy	+1	New	+$80	﹤0.01%	899

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TrustCore Financial Services's ARKG Position: Q4 2022 in Review

TrustCore Financial Services held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2022 at 1 share worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #1031.

TrustCore Financial Services first reported a position in ARKG in Q4 2020 and has held it in 9 quarters since. 321 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

TrustCore Financial Services held 1 share of ARK Genomic Revolution ETF worth $28 as of Q4 2022.
TrustCore Financial Services left its ARK Genomic Revolution ETF share count unchanged in Q4 2022.
ARK Genomic Revolution ETF made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #1031 holding.
TrustCore Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 9 quarters since.
321 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.